Stock Analysis on Net

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Cigna Group, consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

Microsoft Excel
Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Current insurance and contractholder liabilities 5,388 5,477 5,616 5,788 5,514 7,352 7,539 7,166 5,385 6,095 5,654 5,673 5,318 5,917 5,850 5,743 5,308 5,223 5,060 5,030
Pharmacy and other service costs payable 28,465 28,801 27,503 24,284 19,815 19,320 18,617 17,609 17,070 16,676 16,432 15,235 15,309 14,705 14,470 13,762 13,347 12,539 11,856 10,797
Accounts payable 9,294 8,515 9,275 8,118 8,553 7,673 8,072 7,360 7,775 6,870 7,142 6,632 6,655 5,659 5,647 5,640 5,478 5,327 5,413 5,585
Accrued expenses and other liabilities 9,387 8,920 9,003 8,857 9,955 9,668 8,499 9,174 8,006 7,986 7,742 7,833 7,322 7,356 7,212 7,921 8,515 7,153 7,991 7,585
Short-term debt 3,035 2,572 1,717 1,715 2,775 3,046 4,618 3,418 2,993 3,488 2,397 2,173 2,545 2,703 1,532 404 3,374 6,449 4,750 4,340
Liabilities of businesses held for sale 2,410 2,775 2,259 3,215 2,104 5,851 6,116 6,423 7,195 7,109 7,043
Current liabilities 57,979 57,060 55,373 51,977 48,716 47,059 47,345 44,727 41,229 41,115 45,218 43,662 43,572 36,340 34,711 33,470 36,022 43,886 42,179 40,380
Non-current insurance and contractholder liabilities 10,254 10,573 10,449 10,641 10,904 11,286 11,575 11,790 11,481 11,655 11,777 12,167 12,563 16,576 16,665 16,424 16,844 16,213 16,064 15,838
Deferred tax liabilities, net 6,975 6,794 6,953 7,029 7,173 7,480 7,594 7,707 7,751 7,777 8,014 8,110 8,346 8,832 8,867 8,832 8,939 9,142 9,170 9,066
Other non-current liabilities 3,215 3,033 3,538 3,653 3,441 2,932 2,575 2,692 3,142 3,179 3,175 3,346 3,762 4,261 4,330 4,485 4,629 4,552 4,775 4,519
Long-term debt 28,937 30,230 30,175 31,053 28,155 28,094 28,115 29,124 28,100 28,090 30,984 31,013 31,125 31,609 31,606 31,568 29,545 29,537 31,774 32,147
Separate account liabilities 7,278 7,651 7,431 7,416 7,430 7,028 7,324 7,340 7,278 7,260 7,495 8,148 8,337 9,150 9,261 9,088 9,086 8,616 8,261 7,640
Liabilities of businesses held for sale, non-current 591
Non-current liabilities 56,659 58,281 58,546 59,792 57,694 56,820 57,183 58,653 57,752 57,961 61,445 62,784 64,133 70,428 70,729 70,397 69,043 68,060 70,044 69,210
Total liabilities 114,638 115,341 113,919 111,769 106,410 103,879 104,528 103,380 98,981 99,076 106,663 106,446 107,705 106,768 105,440 103,867 105,065 111,946 112,223 109,590
Redeemable noncontrolling interests 107 64 62 78 66 50 45 55 54 56 51 59 58 59 34 35
Common stock, $0.01 par value per share 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4
Additional paid-in capital 31,288 31,186 31,048 30,292 30,669 30,563 30,436 30,332 30,233 29,395 29,930 29,736 29,574 29,077 29,403 29,254 28,975 28,777 28,699 28,554
Accumulated other comprehensive loss (2,341) (2,163) (2,442) (2,324) (1,864) (2,119) (1,878) (1,769) (1,395) (2,009) (2,080) (1,492) (884) (1,153) (1,077) (1,231) (861) (541) (788) (1,527)
Retained earnings 43,519 42,480 42,132 40,978 41,652 40,982 39,936 38,841 37,874 37,041 34,626 33,420 32,593 31,803 30,513 29,389 28,575 24,440 23,052 21,298
Treasury stock, at cost (31,437) (29,412) (29,410) (27,769) (24,238) (23,739) (23,053) (22,906) (21,844) (19,390) (16,588) (15,581) (14,175) (12,316) (10,134) (9,267) (6,372) (4,648) (3,601) (3,250)
Shareholders’ equity 41,033 42,095 41,332 41,181 46,223 45,691 45,445 44,502 44,872 45,041 45,892 46,087 47,112 47,415 48,709 48,149 50,321 48,032 47,366 45,079
Other noncontrolling interests 210 203 195 169 21 11 19 16 13 42 30 22 18 12 7 6 7 7 5 7
Total equity 41,243 42,298 41,527 41,350 46,244 45,702 45,464 44,518 44,885 45,083 45,922 46,109 47,130 47,427 48,716 48,155 50,328 48,039 47,371 45,086
Total liabilities and equity 155,881 157,639 155,446 153,119 152,761 149,645 150,054 147,976 143,932 144,209 152,630 152,610 154,889 154,251 154,207 152,081 155,451 160,044 159,628 154,711

Based on: 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Cigna Group current liabilities increased from Q2 2024 to Q3 2024 and from Q3 2024 to Q4 2024.
Non-current liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Cigna Group non-current liabilities decreased from Q2 2024 to Q3 2024 and from Q3 2024 to Q4 2024.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Cigna Group total liabilities increased from Q2 2024 to Q3 2024 but then slightly decreased from Q3 2024 to Q4 2024.
Shareholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Cigna Group shareholders’ equity increased from Q2 2024 to Q3 2024 but then decreased significantly from Q3 2024 to Q4 2024.